Risk of rhegmatogenous retinal detachment rises following cataract surgery

Article

The investigators undertook a study to determine the incidence of rhegmatogenous retinal detachments 1 year after cataract using the IRIS Registry data and to determine the demographic features, ocular comorbidities, and intraoperative factors associated with an increased risk of detachment development.

Risk of rhegmatogenous retinal detachment rises following cataract surgery

Michael Morano, MD, and colleagues identified the factors that put patients at higher risk of development of a rhegmatogenous retinal detachment (RRD) after cataract surgery. Morano is from Stanley Kimmel Medical College, Thomas Jefferson University, Philadelphia.

The investigators undertook a study to determine the incidence of RRDs 1 year after cataract using the IRIS Registry data and to determine the demographic features, ocular comorbidities, and intraoperative factors associated with an increased risk of detachment development.

Data analysis for rhegmatogenous retinal detachment

The study included 3,177,195 eyes of 1,983,712 patients. Of these, a RRD developed in 6,690 eyes (0.21%) at a median of 139 days after cataract surgery, a rate of about 1 in 500 eyes. Specifically, 15.9% of the RRDs developed within 30 days postoperatively, 37.3% within 90 days, and 59.9% within 180 days, Morano reported.

The highest incidence rate of RRD development was seen in male patients (odds ratio [OR], 3.15; confidence interval [CI], 2.99-3.32); younger age (40-50 years), (OR, 8.61; CI, 7.74-9.58); and eyes with lattice degeneration (OR, 10.53; CI, 9.82-11.28).

Other risk factors included Caucasian race, hypermature cataract, presence of a posterior vitreous detachment, high myopia, and use of a complex cataract surgery code.

“This information,” Morano stated, may guide the informed consent process and identify patients at higher risk for development of an RRD.

Recent Videos
WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology
Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
© 2024 MJH Life Sciences

All rights reserved.